GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » MegaPro Biomedical Co Ltd (ROCO:6827) » Definitions » Accounts Receivable

MegaPro Biomedical Co (ROCO:6827) Accounts Receivable : NT$0.00 Mil (As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is MegaPro Biomedical Co Accounts Receivable?

Accounts Receivable are created when a customer has received a product but has not yet paid for that product. MegaPro Biomedical Co's accounts receivables for the quarter that ended in Dec. 2024 was NT$0.00 Mil.

Accounts receivable can be measured by Days Sales Outstanding.

In Ben Graham's calculation of Net-Net Working Capital, accounts receivable are only considered to be worth 75% of book value. MegaPro Biomedical Co's Net-Net Working Capital per share for the quarter that ended in Dec. 2024 was NT$1.05.


MegaPro Biomedical Co Accounts Receivable Historical Data

The historical data trend for MegaPro Biomedical Co's Accounts Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MegaPro Biomedical Co Accounts Receivable Chart

MegaPro Biomedical Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Accounts Receivable
Get a 7-Day Free Trial - - - - -

MegaPro Biomedical Co Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Accounts Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

MegaPro Biomedical Co Accounts Receivable Calculation

Accounts Receivable is money owed to a business by customers and shown on its Balance Sheet as an asset.


MegaPro Biomedical Co Accounts Receivable Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.

MegaPro Biomedical Co's Days Sales Outstanding for the quarter that ended in Dec. 2024 is calculated as:

2. In Ben Graham's calculation of Net-Net Working Capital (NNWC), MegaPro Biomedical Co's accounts receivable are only considered to be worth 75% of book value:

MegaPro Biomedical Co's Net-Net Working Capital Per Share for the quarter that ended in Dec. 2024 is calculated as:

Net-Net Working Capital Per Share
=(Cash And Cash Equivalents+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(87.676+0.75 * 0+0.5 * 0-19.964
-0-0)/64.721
=1.05

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.

If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.

Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.


MegaPro Biomedical Co Accounts Receivable Related Terms

Thank you for viewing the detailed overview of MegaPro Biomedical Co's Accounts Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


MegaPro Biomedical Co Business Description

Traded in Other Exchanges
N/A
Address
No. 66, Shengyi 5th Road, 10F-1, Hsinchu Science Park, Hsinchu, TWN, 31040
MegaPro Biomedical Co Ltd is a nanomedicine development company. The Company's only reportable operating segment is the Drug Application Development segment, which is engaged in the development of nano-iron oxide IOP drugs.

MegaPro Biomedical Co Headlines

No Headlines